Intercure is engaged in the medical cannabis sector. Co. has two direct subsidiaries, Canndoc Ltd. (Canndoc) and Cannolam Ltd. (Cannolam). Canndoc's operations are focused on the production (including the breeding, cultivating, importing and processing), manufacturing, exporting and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use. Cannolam's operations are focused on establishing and operating dedicated pharmacies for the distribution of pharmaceutical-grade cannabis under the brand name Givol, including a Cookies-branded location. We show 1 historical shares outstanding datapoints in our INCR shares outstanding history coverage, used to compute INCR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing INCR market cap history over the course of time is important for investors
interested in comparing INCR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of INCR versus a peer is one thing; comparing
INCR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like INCR can fluctuate over the course of history.
With this page we aim to empower investors researching INCR by allowing them to research the INCR market cap history. |
Free INCR Email Alerts:
Video: The Importance of Market Cap
